Back to the main directory
EarningsReview / Equity
- Aurora Eiendom (Buy, TP: NOK110.00) - Stable delivery, attractive valuation by DnB Markets
- Boozt (Hold, TP: SEK130.00) - 2024 outlook and FCF in focus by DnB Markets
- It’s all about yields by DnB Markets
- CY24 outlook: Past doubt and into hope by BNP Paribas Exane
- Earnings recovery ahead by BNP Paribas Exane
- Biotage - All eyes on the Astrea acquisition by Danske Bank Equity Research
- Mind the gap by BNP Paribas Exane
- New CEO announcement - unexpected timing by BNP Paribas Exane
- A New Chapter by BNP Paribas Exane
- Low risk and catalyst rich by BNP Paribas Exane
- Trustpilot - Trading updated – Strong margin improvements by Danske Bank Equity Research
- Getting close to 1.5°C by BNP Paribas Exane
- Pharmanutra - Cap des 100M€ franchi ! by MidCap Partners
- Pharmanutra - The €100m Mark Passed! by MidCap Partners
- Industrial Tech 2024 outlook: Safety, semis and secular tailwinds by BNP Paribas Exane
- Q4-23 results and GIP acquisition first take by BNP Paribas Exane
- Chilean Banks by HSBC
- Non material data changes by BNP Paribas Exane
- Is it Over Now (2)? by BNP Paribas Exane
- Indian IT services by HSBC
- Paradox Interactive (Buy, TP: SEK280.00) - Strong potential in 2024e by DnB Markets
- Swedish Orphan Biovitrum (Buy, TP: SEK320.00) - Set for strong Q4 by DnB Markets
- Kone (Hold, TP: EUR46.00) - Eyes on orders and 2024 guidance by DnB Markets
- Bond improvements, new leases, but still-weak transaction markets by DnB Markets
- Weekly news, topics & discussion by DnB Markets